Eli Lilly announces Institute for Genetic Medicine and $700 million investment in Boston Seaport Site Read more
Innovent and Eli Lilly announce final clinical results and biomarker analysis of phase-Ib study of Sintilimab injection plus Bevacizumab biosimilar injection Read more
Experimental Lilly drug neutralises Omicron in lab; slightly higher risk of diabetes seen in kids after COVID Read more
Eli Lilly and Cipla enter into strategic partnership in India to enhance access to Lilly’s key diabetes products Read more
Lilly India gets nod for restricted EU of monoclonal antibody drugs, bamlanivimab and etesevimab to treat COVID-19 Read more
